Serotonin 5-HT2C Receptor RNA Editing Alters Receptor Basal Activity-Reference-Cited by-同舟云学术

Serotonin 5-HT2C Receptor RNA Editing Alters Receptor Basal Activity

Published:2002-06-13 Issue:4 Volume:73 Page:1711-1717
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Herrick-Davis Katharine,Grinde Ellinor,Niswender Colleen M.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1471-4159.1999.731711.x/fullpdf

Reference35 articles.

1. Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor.;Arora;J. Biol. Chem.,1995

2. Functional microdomains in G-proteincoupled receptors : the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor.;Ballesteros;J. Biol. Chem.,1998

3. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.;Barker;J. Biol. Chem.,1994

4. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.;Berg;Mol. Pharmacol,1994

5. 5-Hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.;Berg;Mol. Pharmacol.,1996

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis;The American Journal of Human Genetics;2024-09

2. Ethanol deprivation and central 5-HT deficiency differentially affect the mRNA editing of the 5-HT2C receptor in the mouse brain;Pharmacological Reports;2023-11-03

3. Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis;2023-09-01

4. How RNA editing keeps an I on physiology;American Journal of Physiology-Cell Physiology;2022-11-01

5. Molecular, biochemical and behavioural evidence for a novel oxytocin receptor and serotonin 2C receptor heterocomplex;Neuropharmacology;2021-02